Filing Details
- Accession Number:
- 0001415889-22-005491
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-05-23 16:00:47
- Reporting Period:
- 2022-05-19
- Accepted Time:
- 2022-05-23 16:00:47
- Original Submission Date:
- 2022-05-19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1819411 | Gain Therapeutics Inc. | GANX | Pharmaceutical Preparations (2834) | 851726310 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1851958 | Salvatore Calabrese | C/O Gain Therapeutics, Inc 4800 Montgomery Lane, Suite 220 Bethesda MD 20814 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-19 | 3,000 | $2.70 | 3,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
